Michael Joseph Golembiewski, Chief Financial Officer at SEELOS THERAPEUTICS, INC. (SEEL), bought 83,000 shares at $1.21 ($100K) on 2023-11-30, disclosed to the SEC on 2023-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Several strong factors at once. The rarest rating we give.